Unprovoked bruising and excessive bruising following only moderate trauma has become, in recent years, a familiar complication of prolonged corticosteroid therapy. Nashelsky and Smyth (1958) , reviewing the subject, showed that the lesions were not due to altered capillary fragility or to a clotting defect. Scarborough and Shuster (1960) studied biopsy material from "corticosteroid purpura" and showed that at the site of the lesions there was a loss, and a disorganization, of dermal collagen.
At a recent corticotrophin conference the opinion was expressed that this pathological bruising did not occur in corticotrophin-treated patients (West, 1960) . The purpose of this paper is to substantiate this opinion and to discuss the implications.
Patients.-During the last year 58 patients at one particular follow-up clinic who satisfied the following requirements were examined for evidence of pathological bruising: (1) They were suffering from rheumatoid arthritis or ankylosing spondylitis without any complicating disease of note. (2) They had been receiving corticosteroid therapy for at least 2 years at a mean dose level of 
